Changming An

10PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyChemotherapyNgā pūnaha whakahaere mōhiohio me te mātauranga o te Māori (Māori information and knowledge management systems)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 27, 2026
A Progression-Associated Tumor-Reactive T-Cell Signature Predicts Immunotherapy Response and Reveals ICOS-High CD8 T-Cell Functional States in Head and Neck Squamous Cell Carcinoma.

|Apr 21, 2026
Covalent FAPI Imaging-Guided Precision Surgery in Patients with Medullary Thyroid Carcinoma: A Phase II Clinical Trial.

|Mar 20, 2026
Surgical Management of Right Innominate Interarteriovenous Lymph Node Metastasis in Thyroid Carcinoma: Clinical Features and Operative Experience.

Zhaoyang Wang, Fa Zhang, Qing Zhou

|Feb 24, 2025
Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study.

Yuquan Qian, Le Tang, Jiarui Yao

|Oct 29, 2024
CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma.

Ziren Kong, Zhu Li, Xi-Yang Cui

|May 29, 2024
The machine learning-based model for lateral lymph node metastasis of thyroid medullary carcinoma improved the prediction ability of occult metastasis.

Xiwei Zhang, Xiaohui Zhao, Lichao Jin

Pageof 2

Frequent Collaborators

3 joint publications

Yiming Zhu

3 joint publications

Shaoyan Liu

2 joint publications

Xi-Yang Cui

2 joint publications

Yansong Lin